Results 161 to 170 of about 715,867 (372)
Hepatic Failure: Role for biochemists and nutrition experts [PDF]
, 2002 Nutritional support to hepatic failure patients is challenging and requires experience, skill, careful planning and meticulous follow-up.
Rao Nanjunda, Mr Ananth
core +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.Extracellular matrix (ECM) remodelling biomarkers reflect portal hypertension and disease severity in advanced chronic liver disease (ACLD). However, their predictive value for disease progression is largely restricted to compensated ACLD (cACLD). ABSTRACT Background Extracellular matrix (ECM) remodelling in advanced chronic liver disease (ACLD) is ...
Benedikt Simbrunner +17 more
wiley +1 more source
The Prevalence, Predictors, and In-Hospital Mortality of Hepatic Encephalopathy in Patients with Liver Cirrhosis Admitted at St. Dominic Hospital in Akwatia, Ghana [PDF]
, 2020 Amoako Duah +5 more
openalex +1 more source
Beta-blockers and physical frailty in patients with end-stage liver disease. [PDF]
, 2018 AimTo investigate beta-blocker (BB) use in patients with cirrhosis and determine their effects on physical frailty and overall survival.MethodsAdult outpatients with cirrhosis listed for liver transplantation underwent testing of physical frailty using ...
Hayssen, Hilary +3 more
core
Alimentary Pharmacology &Therapeutics, EarlyView.Recompensation is a heterogeneous and dynamic state in HBV‐related decompensated cirrhosis; The prognosis for patients with unstable recompensation was found to be worse compared to those with stable recompensation, but still better than patients without recompensation; Subclassification of recompensation has significant implications for prognosis and ...
Shuai Xia +19 more
wiley +1 more source
First Latin American consensus on the treatment and prophylaxis of hepatic encephalopathy
Annals of HepatologyIntroduction and Objectives: Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis, leading to rapid deterioration and increased mortality.
Fátima Higuera-de-la-Tijera +14 more
doaj +1 more source
Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy [PDF]
, 2021 Mandip Kc +3 more
openalex +1 more source
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis [PDF]
, 2016 Background Non-absorbable disaccharides (lactulose and lactitol) are recommended as first-line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non-absorbable ...
Gluud, LL, Morgan, MY, Vilstrup, H
core
Alimentary Pharmacology &Therapeutics, EarlyView.Indocyanine green clearance by pulse dye densitometry correlates with portal hypertension, systemic inflammation and circulatory dysfunction in advanced chronic liver disease. While diagnostic accuracy for CSPH was limited, ICG‐R15 independently predicted decompensation and ACLF/liver‐related mortality, highlighting its prognostic value across disease ...
Mathias Jachs +17 more
wiley +1 more source
Huli yanjiu, 2021 ObjectiveTo investigate the cognition，attitude and screening status of medical staff towards covert hepatic encephalopathy，so as to provide reference for management plan for covert hepatic encephalopathy.MethodsUsing convenience sampling method，totally 1
LIU Siqin +4 more
doaj